Skip to main content

Advertisement

Log in

Pigment epithelium-derived factor as a multifunctional antitumor factor

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

The design of new therapeutic strategies for cancer treatment is based on the combination of drugs directed against different tumor compartments, including the tumor cells themselves and components of the stroma, such as the tumor vasculature. Indeed, several antiangiogenic compounds have entered clinical trials for use alone or in combination with conventional cytotoxic drugs. Pigment epithelium-derived factor (PEDF) is a multifunctional natural peptide with complex neurotrophic, neuroprotective, antiangiogenic, and proapoptotic biological activities, any of which could potentially be exploited for therapeutic purposes. This review summarizes recent studies that reveal the antitumor potential of PEDF based on its antiangiogenic properties and its newly discovered direct antitumor effects, which involve the induction of differentiation or apoptosis in tumor cells. We also discuss possible therapeutic applications of PEDF, based on these mechanistic insights and on the identification of functional domains that retain specific biological activities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

PEDF:

pigment epithelium-derived factor

TSP-1:

thrombospondin-1

VEGF:

vascular endothelial growth factor

bFGF:

basic-fibroblast growth factor

NFATc2:

nuclear factor of activated T cells

c-FLIP:

cellular-FLICE-like inhibitory protein

VEGF-R1:

vascular endothelial growth factor receptor-1

NF-κB:

nuclear factor-κB

JNK:

c-Jun NH2-terminal kinase

MMP-9:

matrix metalloproteinase-9

Ad-PEDF:

adenovirus-PEDF

References

  1. Tombran-Tink J, Johnson LV (1989) Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 30:1700–1707

    PubMed  CAS  Google Scholar 

  2. Pignolo RJ, Cristofalo VJ, Rotenberg MO (1993) Senescent WI-38 cells fail to express EPC-1, a gene induced in young cells upon entry into the G0 state. J Biol Chem 268:8949–8957

    PubMed  CAS  Google Scholar 

  3. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245–248

    Article  PubMed  CAS  Google Scholar 

  4. Jimenez B, Volpert OV (2001) Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 78:663–672

    Article  PubMed  CAS  Google Scholar 

  5. Bouck N (2002) PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 8:330–334

    Article  PubMed  CAS  Google Scholar 

  6. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8:349–357

    Article  PubMed  CAS  Google Scholar 

  7. Zaichuk TA, Shroff EH, Emmanuel R, Filleur S, Nelius T, Volpert OV (2004) Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J Exp Med 199:1513–1522

    Article  PubMed  CAS  Google Scholar 

  8. Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604–3613

    Article  PubMed  CAS  Google Scholar 

  9. Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE (2003) Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9:774–780

    Article  PubMed  CAS  Google Scholar 

  10. Abramson LP, Stellmach V, Doll JA, Cornwell M, Arensman RM, Crawford SE (2003) Wilms’ tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J Pediatr Surg 38:336–342

    Article  PubMed  Google Scholar 

  11. Crawford SE, Stellmach V, Ranalli M, Huang X, Huang L, Volpert O, De Vries GH, Abramson LP, Bouck N (2001) Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci 114:4421–4428

    PubMed  CAS  Google Scholar 

  12. Hase R, Miyamoto M, Uehara H, Kadoya M, Ebihara Y, Murakami Y, Takahashi R, Mega S, Li L, Shichinohe T, Kawarada Y, Kondo S (2005) Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res 11:8737–8744

    Article  PubMed  CAS  Google Scholar 

  13. Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M (2004) Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res 64:5632–5642

    Article  PubMed  CAS  Google Scholar 

  14. Abe R, Shimizu T, Yamagishi S, Shibaki A, Amano S, Inagaki Y, Watanabe H, Sugawara H, Nakamura H, Takeuchi M, Imaizumi T, Shimizu H (2004) Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164:1225–1232

    PubMed  CAS  Google Scholar 

  15. Halin S, Wikstrom P, Rudolfsson SH, Stattin P, Doll JA, Crawford SE, Bergh A (2004) Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Cancer Res 64:5664–5671

    Article  PubMed  CAS  Google Scholar 

  16. Uehara H, Miyamoto M, Kato K, Ebihara Y, Kaneko H, Hashimoto H, Murakami Y, Hase R, Takahashi R, Mega S, Shichinohe T, Kawarada Y, Itoh T, Okushiba S, Kondo S, Katoh H (2004) Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 64:3533–3537

    Article  PubMed  CAS  Google Scholar 

  17. Guan M, Yam HF, Su B, Chan KP, Pang CP, Liu WW, Zhang WZ, Lu Y (2003) Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol 56:277–282

    Article  PubMed  CAS  Google Scholar 

  18. Matsumoto K, Ishikawa H, Nishimura D, Hamasaki K, Nakao K, Eguchi K (2004) Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 40:252–259

    Article  PubMed  CAS  Google Scholar 

  19. Quan GM, Ojaimi J, Nadesapillai AP, Zhou H, Choong PF (2002) Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. Pathobiology 70:361–367

    Article  PubMed  Google Scholar 

  20. Quan GM, Ojaimi J, Li Y, Kartsogiannis V, Zhou H, Choong PF (2005) Localization of pigment epithelium-derived factor in growing mouse bone. Calcif Tissue Int 76:146–153

    Article  PubMed  CAS  Google Scholar 

  21. Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53:411–414

    Article  PubMed  CAS  Google Scholar 

  22. Houenou LJ, D’Costa AP, Li L, Turgeon VL, Enyadike C, Alberdi E, Becerra SP (1999) Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J Comp Neurol 412:506–514

    Article  PubMed  CAS  Google Scholar 

  23. Araki T, Taniwaki T, Becerra SP, Chader GJ, Schwartz JP (1998) Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J Neurosci Res 53:7–15

    Article  PubMed  CAS  Google Scholar 

  24. DeCoster MA, Schabelman E, Tombran-Tink J, Bazan NG (1999) Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons. J Neurosci Res 56:604–610

    Article  PubMed  CAS  Google Scholar 

  25. Bilak MM, Corse AM, Bilak SR, Lehar M, Tombran-Tink J, Kuncl RW (1999) Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 58:719–728

    PubMed  CAS  Google Scholar 

  26. Cao W, Tombran-Tink J, Chen W, Mrazek D, Elias R, McGinnis JF (1999) Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res 57:789–800

    Article  PubMed  CAS  Google Scholar 

  27. Ogata N, Wang L, Jo N, Tombran-Tink J, Takahashi K, Mrazek D, Matsumura M (2001) Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr Eye Res 22:245–252

    Article  PubMed  CAS  Google Scholar 

  28. Takita H, Yoneya S, Gehlbach PL, Duh EJ, Wei LL, Mori K (2003) Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4497–4504

    Article  PubMed  Google Scholar 

  29. Cayouette M, Smith SB, Becerra SP, Gravel C (1999) Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis 6:523–532

    Article  PubMed  CAS  Google Scholar 

  30. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF (2001) In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 42:1646–1652

    PubMed  CAS  Google Scholar 

  31. Ramirez-Castillejo C, Sanchez-Sanchez F, Andreu-Agullo C, Ferron SR, Aroca-Aguilar JD, Sanchez P, Mira H, Escribano J, Farinas I (2006) Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci 9:331–339

    Article  PubMed  CAS  Google Scholar 

  32. Filleur S, Volz K, Nelius T, Mirochnik Y, Huang H, Zaichuk TA, Aymerich MS, Becerra SP, Yap R, Veliceasa D, Shroff EH, Volpert OV (2005) Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res 65:5144–5152

    Article  PubMed  CAS  Google Scholar 

  33. Tombran-Tink J, Barnstable CJ (2003) PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci 4:628–636

    Article  PubMed  CAS  Google Scholar 

  34. Tombran-Tink J (2005) The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci 10:2131–2149

    PubMed  CAS  Google Scholar 

  35. Yabe T, Wilson D, Schwartz JP (2001) NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem 276:43313–43319

    Article  PubMed  CAS  Google Scholar 

  36. Bilak MM, Becerra SP, Vincent AM, Moss BH, Aymerich MS, Kuncl RW (2002) Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J Neurosci 22:9378–9386

    PubMed  CAS  Google Scholar 

  37. Alberdi E, Aymerich MS, Becerra SP (1999) Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor. J Biol Chem 274:31605–31612

    Article  PubMed  CAS  Google Scholar 

  38. Aymerich MS, Alberdi EM, Martinez A, Becerra SP (2001) Evidence for pigment epithelium-derived factor receptors in the neural retina. Invest Ophthalmol Vis Sci 42:3287–3293

    PubMed  CAS  Google Scholar 

  39. Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M (2002) Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes. Int J Tissue React 24:137–142

    PubMed  CAS  Google Scholar 

  40. Tsao YP, Ho TC, Chen SL, Cheng HC (2006) Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. Life Sci 79:545–550

    Article  PubMed  CAS  Google Scholar 

  41. Maik-Rachline G, Shaltiel S, Seger R (2005) Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood 105:670–678

    Article  PubMed  CAS  Google Scholar 

  42. Maik-Rachline G, Seger R (2006) Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function. Blood 107:2745–2752

    Article  PubMed  CAS  Google Scholar 

  43. Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y (2004) Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11:325–332

    Article  PubMed  CAS  Google Scholar 

  44. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T (2005) Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77:3231–3241

    Article  PubMed  CAS  Google Scholar 

  45. Notari L, Miller A, Martinez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP (2005) Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 46:2736–2747

    Article  PubMed  Google Scholar 

  46. Kozaki K, Miyaishi O, Koiwai O, Yasui Y, Kashiwai A, Nishikawa Y, Shimizu S, Saga S (1998) Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells. J Biol Chem 273:15125–15130

    Article  PubMed  CAS  Google Scholar 

  47. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526

    Article  PubMed  CAS  Google Scholar 

  48. Sheng S, Pemberton PA, Sager R (1994) Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 269:30988–30993

    PubMed  CAS  Google Scholar 

  49. Blacque OE, Worrall DM (2002) Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277:10783–10788

    Article  PubMed  CAS  Google Scholar 

  50. Meyer C, Notari L, Becerra SP (2002) Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem 277:45400–45407

    Article  PubMed  CAS  Google Scholar 

  51. Mahtabifard A, Merritt RE, Yamada RE, Crystal RG, Korst RJ (2003) In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies. J Thorac Cardiovasc Surg 126:28–38

    Article  PubMed  CAS  Google Scholar 

  52. Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY (2004) Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci U S A 101:6605–6610

    Article  PubMed  CAS  Google Scholar 

  53. Simonovic M, Gettins PG, Volz K (2001) Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor. Proc Natl Acad Sci U S A 98:11131–11135

    Article  PubMed  CAS  Google Scholar 

  54. Gillis P, Savla U, Volpert OV, Jimenez B, Waters CM, Panos RJ, Bouck NP (1999) Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci 112(Pt 12):2049–2057

    PubMed  CAS  Google Scholar 

  55. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N (1993) Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497–511

    Article  PubMed  CAS  Google Scholar 

  56. Chen ZS, Pohl J, Lawley TJ, Swerlick RA (1996) Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism. J Invest Dermatol 106:215–220

    Article  PubMed  CAS  Google Scholar 

  57. Shafiee A, Penn JS, Krutzsch HC, Inman JK, Roberts DD, Blake DA (2000) Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci 41:2378–2388

    PubMed  CAS  Google Scholar 

  58. Haviv F, Bradley MF, Kalvin DM, Schneider AJ, Davidson DJ, Majest SM, McKay LM, Haskell CJ, Bell RL, Nguyen B, Marsh KC, Surber BW, Uchic JT, Ferrero J, Wang YC, Leal J, Record RD, Hodde J, Badylak SF, Lesniewski RR, Henkin J (2005) Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities. J Med Chem 48:2838–2846

    Article  PubMed  CAS  Google Scholar 

  59. Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA (2002) Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 43:2428–2434

    PubMed  Google Scholar 

  60. Mori K, Gehlbach P, Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA (2002) AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43:1994–2000

    PubMed  Google Scholar 

  61. Auricchio A, Behling KC, Maguire AM, O’Connor EM, Bennett J, Wilson JM, Tolentino MJ (2002) Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol Ther 6:490–494

    Article  PubMed  CAS  Google Scholar 

  62. Gehlbach P, Demetriades AM, Yamamoto S, Deering T, Duh EJ, Yang HS, Cingolani C, Lai H, Wei L, Campochiaro PA (2003) Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther 10:637–646

    Article  PubMed  CAS  Google Scholar 

  63. Raisler BJ, Berns KI, Grant MB, Beliaev D, Hauswirth WW (2002) Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1–3 of angiostatin reduce retinal neovascularization. Proc Natl Acad Sci U S A 99:8909–8914

    Article  PubMed  CAS  Google Scholar 

  64. Wang L, Schmitz V, Perez-Mediavilla A, Izal I, Prieto J, Qian C (2003) Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor. Mol Ther 8:72–79

    Article  PubMed  CAS  Google Scholar 

  65. Streck CJ, Zhang Y, Zhou J, Ng C, Nathwani AC, Davidoff AM (2005) Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg 40:236–243

    Article  PubMed  Google Scholar 

  66. Merritt RE, Yamada RE, Wasif N, Crystal RG, Korst RJ (2004) Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma. Ann Thorac Surg 78:1042–1051

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Supported by grant SAF 2004-04152 to B. Jimenez and R01HL068033 grant to O.V. Volpert. N.I. Fernandez-Garcia has been supported by a Comunidad Autonoma de Madrid fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Jimenez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernandez-Garcia, N.I., Volpert, O.V. & Jimenez, B. Pigment epithelium-derived factor as a multifunctional antitumor factor. J Mol Med 85, 15–22 (2007). https://doi.org/10.1007/s00109-006-0111-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-006-0111-z

Keywords

Navigation